A detailed history of Pay Pay Securities Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Pay Pay Securities Corp holds 23 shares of LLY stock, worth $18,300. This represents 1.81% of its overall portfolio holdings.

Number of Shares
23
Previous 15 53.33%
Holding current value
$18,300
Previous $13.6 Million 50.04%
% of portfolio
1.81%
Previous 1.13%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$772.14 - $960.02 $6,177 - $7,680
8 Added 53.33%
23 $20.4 Million
Q2 2024

Jul 31, 2024

SELL
$724.87 - $909.04 $6,523 - $8,181
-9 Reduced 37.5%
15 $13.6 Million
Q1 2024

Apr 17, 2024

BUY
$592.2 - $792.28 $592 - $792
1 Added 4.35%
24 $18.7 Million
Q4 2023

Jan 30, 2024

SELL
$525.19 - $619.13 $1,050 - $1,238
-2 Reduced 8.0%
23 $13.9 Million
Q3 2023

Oct 30, 2023

BUY
$434.7 - $599.3 $10,867 - $14,982
25 New
25 $13.4 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Pay Pay Securities Corp Portfolio

Follow Pay Pay Securities Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pay Pay Securities Corp, based on Form 13F filings with the SEC.

News

Stay updated on Pay Pay Securities Corp with notifications on news.